Phase 1 dose-finding study to evaluate safety and tolerability of CVGBM in patients with newly diagnosed and surgically resected MGMT-unmethylated glioblastoma.

被引：0

作者：

Tabatabai, Ghazaleh

Von Baumgarten, Louisa

Van Den Bent, Martin J.

Burger, Michael C.

Freres, Pierre

Glas, Martin

Hau, Peter

Herrlinger, Ulrich

Mildenberger, Iris

Neyns, Bart

Schafer, Henning Sebastian

Seidel, Clemens

Galot, Rachel

Wick, Antje

Falk, Martin H.

Chama, Laura Leticia de Freitas

Kelemen, Peter

Koch, Sven D.

Roche, Paula Romer

Gnad-Vogt, Senta Ulrike

机构：

[1] Eberhard Karls Univ Tubingen, Hertie Inst Clin Brain Res, Univ Hosp Tubingen, Dept Neurol & Interdisciplinary Neuro Oncol, Tubingen, Germany

[2] Comprehens Canc Ctr Tubingen Stuttgart, Ctr Neuro Oncol, Tubingen, Germany

[3] Ludwig Maximilians Univ Munchen, LMU Univ Hosp, Dept Neurosurg, Munich, Germany

[4] Erasmus MC Canc Inst, Rotterdam, Netherlands

[5] Goethe Univ Hosp, Dr Senckenberg Inst Neurooncol, Frankfurt, Germany

[6] Liege Univ Hosp, Liege, Belgium

[7] Univ Med Essen, Univ Duisburg Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany

[8] Univ Med Essen, Univ Duisburg Essen, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[9] Univ Hosp Regensburg, Dept Neurol, Regensburg, Germany

[10] Univ Hosp Regensburg, Wilhelm Sander Therapy Unit, Regensburg, Germany

[11] Univ Hosp Bonn, Div Clin Neuro Oncol, Dept Neurol, Bonn, Germany

[12] Heidelberg Univ, Med Fac Mannheim, Dept Neurol, Mannheim, Germany

[13] Heidelberg Univ, Mannheim Ctr Translat Neurosci MCTN, Mannheim, Germany

[14] Univ Ziekenhuis Brussel, Brussels, Belgium

[15] Univ Freiburg, Dept Radiat Oncol, Med Ctr, Freiburg, Germany

[16] German Canc Res Ctr, Partner Site Freiburg, German Canc Consortium DKTK, Freiburg, Germany

[17] Univ Leipzig, Dept Radiat Oncol, Med Ctr, Leipzig, Germany

[18] Partner Site Leipzig, Comprehens Canc Ctr Cent Germany, Leipzig, Germany

[19] Univ Hosp St Luc, Brussels, Belgium

[20] Heidelberg Univ Hosp, Dept Neurol, Heidelberg, Germany

[21] CureVac SE, Wiesbaden, Germany

[22] CureVac SE, Tubingen, Germany

[23] Curevac SE, Wiesbaden, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS2095

引用

页数：1